向铁灭以消除衰老细胞:机制和治疗潜力
Sanjay Kumar Kureel1, Blake B Rasmussen1,2
1Barshop Institute for Longevity & Aging Studies, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Aging and disease
|August 6, 2025
概括
铁灭,一种新的细胞死亡方法,通过诱导氧化损伤,有效地消除衰老细胞 (SCs). 这种方法为治疗与年龄相关疾病的传统老年化药物提供了有希望的替代方案.
科学领域:
- 生物医学科学 生物医学科学
- 细胞生物学 细胞生物学
- 衰老研究研究 衰老研究
背景情况:
- 细胞衰老在发育和瘤抑制中起作用,但当细胞积累时,会导致与年龄相关的疾病.
- 衰老细胞 (SCs) 呈现不可逆转的细胞循环停止,抗亡蛋白过度表达,以及与衰老相关的分泌表型 (SASP),导致组织功能障碍.
- 针对亡的常规老化药具有局限性,包括某些SCs的选择性和耐药性差.
研究的目的:
- 审查铁灭的机制,一个依赖于铁的编程细胞死亡,作为一个老化策略.
- 为了评估ferroptosis对于与年龄有关的病理的治疗潜力.
- 为了突出铁灭症作为下一代的老化疗法.
主要方法:
- 文献综述侧重于老化的细胞中的铁灭诱导.
- 分析涉及铁,多不和脂肪酸 (PUFA) 和氧化损伤的分子机制.
- 评估铁灭菌对抗纤维化,癌症和神经退行等与年龄有关的疾病的疗效.
主要成果:
- 衰老细胞可以通过铁灭绝有效地被消除,这是由于它们对灭的抵抗力.
- 铁亡利用氧化损伤来克服SCs中的抗亡防御.
- 铁含量升高和PUFAs是 Ferroptosis驱动的SCs消除的关键媒介.
结论:
- 铁亡是一种清除衰老细胞的强有力的机制,与传统的诱导亡的老化药物相比,具有优势.
- 基于铁质的疗法显示出治疗各种与年龄有关的疾病的巨大潜力,包括纤维化,动脉样硬化,关节炎和神经退行症.
- 应对转化挑战对于实现铁亡的全部潜力至关重要,因为它是治疗衰老和相关疾病的下一代老化疗法.
相关概念视频
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Overview of Cell Death
7.7K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.7K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K


